Search for New Methods for Cancer Diagnosis

  • Rusudan Sujashvili Ivane Beritashvili Center of Experimental Biomedicine, Tbilisi, Georgia, University of Georgia, Tbilisi, Georgia
  • Sophiya Tsitsilashvili Research Institute of Clinical Medicine Todua Clinics, Tbilisi, Georgia
  • Nina Gvinadze Ivane Beritashvili Center of Experimental Biomedicine, Tbilisi, Georgia
Keywords: cancer, ubiquitin, diagnostics

Abstract

Numerous cellular components are being studied to identify new possibilities for effective cancer diagnosis. Researchers have proposed proteins, miRNA, micronuclei, DNA, and other biochemical or cytological objects as potential markers and targets for disease detection and management. Often quantitative changes of these objects, increase or decrease, are observed in the blood serum of patients, which correlates with the severity of the disease or the effectiveness of treatment. In this regard, today, as never before, the issue of cancer management is acute and the study of cellular proteins is highly appropriate and effective. Management of cellular processes is associated with the activation and inhibition of various metabolic pathways. Typically, manipulating a single protein causes a chain initiation of multiple reactions. It is therefore difficult to say unequivocally that quantitative modification, activation or inhibition of this or that protein may be an unconditional marker or target to solve the above-mentioned problem. It is common for proteins already recognized as markers to manifest themselves differently in individuals. We therefore believe that the study of diagnostic agents should be conducted in a complex manner parallel to the metabolic pathways associated with corresponding proteins. We investigated changes of ubiquitin levels in blood serum of cancer patients and healthy volunteers. Elisa test and subsequent statistical analysis were used for assessment. The results indicate the necessity of further investigation of ubiquitin  and other proteins that may react or indirectly affect ubiquitin level variability.

References

. Pickart, C. M. (2001). Mechanisms Underlying Ubiquitination. Annual Review of Biochemistry, 70(1), 503–533. https://doi.org/10.1146/annurev.biochem.70.1.503

. Daulny, A., & Tansey, W. P. (2009). Damage control: DNA repair, transcription, and the ubiquitin–proteasome system. DNA Repair, 8(4):444-448. https://doi.org/10.1016/j.dnarep.2009.01.017

. Li, W., & Ye, Y. (2008). Polyubiquitin chains: functions, structures, and mechanisms. Cellular and Molecular Life Sciences, 65(15):2397-2406. https://doi.org/10.1007/s00018-008-8090-6

. Popovic, D., Vucic, D., & Dikic, I. (2014). Ubiquitination in disease pathogenesis and treatment. Nature Medicine, 20(11):1242-1253. https://doi.org/10.1038/nm.3739

. Kubaichuk, K., & Kietzmann, T. (2019). Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance. Cells, 8(6):598. https://doi.org/10.3390/cells8060598

. Lei, H., Shan, H., & Wu, Y. (2017). Targeting deubiquitinating enzymes in cancer stem cells. Cancer Cell International, 17(1). https://doi.org/10.1186/s12935-017-0472-0

. Chiavarina, B., Martinez-Outschoorn, U. E., Whitaker-Menezes, D., Howell, A., Tanowitz, H. B., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2012). Metabolic reprogramming and two-compartment tumor metabolism. Cell Cycle, 11(17):3280-3289. https://doi.org/10.4161/cc.21643

. Liu, D. (2019). Cancer biomarkers for targeted therapy. Biomarker Research, 7(1). https://doi.org/10.1186/s40364-019-0178-7

. Moser, E., & Oliver, P. M. (2019). Special Issue: E3 ubiquitin ligases, the matchmakers and grim reapers of immune cells. Cellular Immunology, 340, 103924. https://doi.org/10.1016/j.cellimm.2019.103924

. Nguyen, T., & Kugler, J. M. (2018). Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer. Cancers, 10(4), 121. https://doi.org/10.3390/cancers10040121

. Sixt, S. U., & Dahlmann, B. (2008). Extracellular, circulating proteasomes and ubiquitin — Incidence and relevance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1782(12), 817–823. https://doi.org/10.1016/j.bbadis.2008.06.005

. Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020). The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduction and Targeted Therapy, 5(1). https://doi.org/10.1038/s41392-020-0107-0

Published
2021-11-18
How to Cite
Rusudan Sujashvili, Sophiya Tsitsilashvili, & Nina Gvinadze. (2021). Search for New Methods for Cancer Diagnosis. International Journal of Applied Sciences: Current and Future Research Trends , 12(1), 13-18. Retrieved from https://ijascfrtjournal.isrra.org/index.php/Applied_Sciences_Journal/article/view/1178
Section
Articles